or Try an Advanced Search...

    Therapies For The Treatment Of Autoimmune Diseases Stocks List

    Symbol Grade Name % Change
    ARGX B argenx SE -0.05
    RNAC F Cartesian Therapeutics, Inc. 11.73
    View As Page of Charts
    Related Industries: Biotechnology
    Related Stock Lists: Autoimmune Disease Myasthenia Gravis Acute Myeloid Leukemia Autoimmunity Biopharmaceutical Cancer Cancer Immunotherapy Cell Therapy Dyslipidemia Hematological Cancers Immunotherapy Inflammation Janus Kinase Inhibitor Lipid Lupus Lymphoma Myasthenia Myelodysplastic Syndrome Rgx Rheumatoid Arthritis

    Related ETFs - A few ETFs which own one or more of the above listed Therapies For The Treatment Of Autoimmune Diseases stocks.

    Symbol Grade Name Weight
    EWK C iShares MSCI Belgium Capped Investable Market Index Fund 6.71
    BBH B Market Vectors Biotech ETF 5.18
    IBRN D iShares Neuroscience and Healthcare ETF 4.65
    FBT B First Trust Amex Biotech Index Fund 3.71
    MNTL B Tema Neuroscience and Mental Health ETF 3.58
    View all Therapies For The Treatment Of Autoimmune Diseases ETFs...
    Compare ETFs
    Compare BBH to FBT Compare BBH to IBRN Compare EWK to IBRN

        Therapies For The Treatment Of Autoimmune Diseases Stocks Recent News

        Date Stock Title
        Jul 2 RNAC Cartesian Therapeutics Strengthens Board of Directors with Appointment of Kemal Malik
        Jul 2 RNAC Cartesian: Further Value To Be Unlocked After Positive MG Treatment Data
        Jul 2 RNAC Cartesian Therapeutics Plummets On 'Watershed Moment' For CAR-T Drugs
        Jul 2 RNAC Cartesian posts mid-stage win for lead asset; nabs $130M in financing
        Jul 2 RNAC Cartesian Therapeutics Announces First Patient Dosed in Phase 2 Trial of Descartes-08 in Systematic Lupus Erythematosus
        Jul 2 RNAC Cartesian Therapeutics Announces $130 Million Private Placement Equity Financing
        Jul 2 RNAC Cartesian Therapeutics Announces Positive Topline Results from Phase 2b Trial of Descartes-08 in Patients with Myasthenia Gravis
        Jun 28 ARGX Argenx: Strong Setup For Outperformance In 2025
        Related Industries: Biotechnology
        Related Stock Lists: Autoimmune Disease Myasthenia Gravis Acute Myeloid Leukemia Autoimmunity Biopharmaceutical Cancer Cancer Immunotherapy Cell Therapy Dyslipidemia Hematological Cancers Immunotherapy Inflammation Janus Kinase Inhibitor Lipid Lupus Lymphoma Myasthenia Myelodysplastic Syndrome Rgx Rheumatoid Arthritis
        Therapies For The Treatment Of Autoimmune Diseases

        Browse All Tags